Esophagectomy Clinical Trial
Official title:
Prediction of Anastomotic Leak/Stricture After Esophagectomy With Gastric Pull-up by Venous Blood Gas
Esophageal resection becomes a routine surgical procedure in many medical centers. Usually
reconstruction after esophagectomy is achieved by gastric pull-up with cervical or
intrathoracic anastomosis. The only blood supply for this gastric tube is by right
gastroepiploic arcade. Bad or borderline perfusion of gastric tube is the main reason for
future anastomotic leaks or strictures.
The investigators suggest to measure components of venous blood gases (O2, pH, CO2, lactate)
from the area of future anastomosis before construction of gastric tube and just before
creation of anastomosis ( after 15-30 minutes), compare the results of this analysis with
systemic venous blood.
The investigators suppose that elevation of acid features of blood (pH decreasing, lactate
increasing etc.) as expression of tissue ischemia after gastric tube creation maybe the
significant predictive sign for future anastomotic leaks or strictures.
After operation the investigators plan to find relationship between the blood gas changes
and rate of anastomotic leak and stricture.
This is prospective study. Anticipated cohort of 50 patients
Prediction of Anastomotic Leak/Stricture after Esophagectomy with Gastric Pull-up by Venous
Blood Gas.
Esophageal resection becomes a routine surgical procedure in many medical centers. Usually
reconstruction after esophagectomy is achieved by gastric pull-up with cervical or
intrathoracic anastomosis. The only blood supply for this gastric tube is by right
gastroepiploic arcade. Bad or borderline perfusion of gastric tube is the main reason for
future anastomotic leaks or strictures.
There are a lot of methods for intraoperative assessment of gastric tube perfusion. This
methods include basic (as color, temperature of tube) and advanced assessment as optical
fiber spectroscopy, visible light spectroscopy, the combination of a laser Doppler flowmeter
and spectrophotometer, a laser Doppler imager, partial tissue oxygen pressure with a
Clark-type polar graphic oxygen electrode, continuous measurement of mucosal PCO2 using
recirculation gas analysis with a TONOCAP device together with mean arterial pressure
measurement, and cardiac output and systemic vascular resistance by pulse contour analysis
laser-assisted fluorescent-dye angiography (1-5).
All this methods are comparative complicated and do not promise good assessment results.
The investigators suggest to measure components of venous blood gases (O2, pH, CO2, lactate)
from the area of future anastomosis before construction of gastric tube and just before
creation of anastomosis ( after 15-30 minutes), compare the results of this analysis with
systemic venous blood.
The investigators suppose that elevation of acid features of blood (pH decreasing, lactate
increasing etc.) as expression of tissue ischemia after gastric tube creation maybe the
significant predictive sign for future anastomotic leaks or strictures.
After operation the investigators plan to find relationship between the blood gas changes
and rate of anastomotic leak and stricture.
Objectives The aims of this study is to compare the changes in venous blood gas in gastric
tube together with systemic venous blood before construction of gastric tube and just before
creation of anastomosis . After operation the investigators plan to find relationship
between the blood gas changes and rate of anastomotic leak and stricture.
Study Design This is prospective study. Anticipated cohort of 50 patients The investigators
are planning to take 1-2 cc of venous blood from proximal part of stomach before gastric
tube creation and in the same time the investigators will take same amount of venous blood
from peripheral vein. This blood will be analyzed in the "ABL800 FLEX blood gas analyzer"
(Radiometer Copenhagen) as a routine blood analyses that making by anesthesiologist during
the operation. This blood sampling the investigators will make again after 15-30 minutes
from the same area in proximal stomach (after creation of gastric tube) and peripheral vein
just before anastomosis creation. Important that because of technical needs (regardless our
study) this stomach area from where the investigators are going to get blood for analyses
will be removed immediately after anastomosis creation. So there is no danger for future
injury or tissue changes for the patient due to needle stubbing for blood analyses.
Every patient will undergo routine follow up in the surgical department for minimum 7-10
hospitalization days with describing signs of anastomotic leak. Patients will continue
routine follow up in our outpatient clinic (as every patient after such kind of surgery) two
weeks, 6 weeks and 3 months after discharge from surgical department with evaluation of
anastomotic stricture signs.
Participants. Inclusion criteria Patients who scheduled to undergo elective esophagectomy
with gastric pull-up reconstruction in Beilinson hospital and are willing and able to give
inform consent.
Data collection and statistical analysis. Data will be collected about patients demographic
data, comorbidities, kind of pathology, neoadjuvant treatment (for cancer patients), time of
surgery, patient hemodynamic state during surgery. The investigators will collect blood
results especially measure of O2, pH, CO2, lactate. After surgery the investigators will
describe and collect clinical and radiological signs of anastomotic leak and stricture.
Statistical analysis. Logistic regression and ROC (receiver operating characteristic) will
be used to assess relationship between the blood gas changes and rate of anastomotic leak
and stricture.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00827931 -
Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery
|
Phase 4 | |
Completed |
NCT00420017 -
Prevention of Atrial Fibrillation Following Esophagectomy
|
Phase 4 | |
Recruiting |
NCT04750096 -
Esophagectomy Enhanced Recovery After Surgery Protocol
|
||
Not yet recruiting |
NCT06147180 -
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
|
||
Active, not recruiting |
NCT03740542 -
Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy
|
N/A | |
Recruiting |
NCT03835273 -
Oesophagectomy and Chest Wall and Respiratory Function
|
||
Enrolling by invitation |
NCT02086461 -
Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay
|
N/A | |
Recruiting |
NCT00260559 -
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
|
||
Recruiting |
NCT02017002 -
Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer
|
N/A | |
Recruiting |
NCT04654975 -
Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
|
||
Recruiting |
NCT04008420 -
The Association of Intraoperative Oxygen Reserve Index and Postoperative Pulmonary Complications in Robot-assisted Esophagectomy
|
||
Recruiting |
NCT01144325 -
Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position
|
Phase 2 | |
Completed |
NCT01169051 -
A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer Surgery
|
N/A | |
Recruiting |
NCT05950438 -
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
|
||
Not yet recruiting |
NCT06271707 -
Stellate Ganglion Block
|
Phase 4 | |
Recruiting |
NCT02418052 -
Effect of Neck Flexion on Esophagogastric Anastomotic Leakage After MIE
|
N/A | |
Completed |
NCT02158286 -
Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet
|
N/A | |
Recruiting |
NCT02309619 -
Lifting of Gastric Tube Through Trans-substernal Versus Trans-esophageal Bed Path in MIE
|
N/A | |
Completed |
NCT05604950 -
Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
|
||
Completed |
NCT00708513 -
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
|
N/A |